- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Agfa brings TeraRecon’s 3D to IMPAX
The effects of an agreement signed in the run-up to RSNA 2010 changed the IT approaches of two companies on the exhibit floor, TeraRecon and Agfa HealthCare. One week before the imaging community trekked to Chicago, these two companies cut a deal to make TeraRecon’s thin-client iNtuition an integral part of Agfa’s IMPAX 6 PAC system
The effects of an agreement signed in the run-up to RSNA 2010 changed the IT approaches of two companies on the exhibit floor, TeraRecon and Agfa HealthCare. One week before the imaging community trekked to Chicago, these two companies cut a deal to make TeraRecon’s thin-client iNtuition an integral part of Agfa’s IMPAX 6 PAC system.
Both companies are touting the integrated product at their booths on the RSNA 2010 exhibit floor. Purchasers don’t have to buy TeraRecon’s thin-client system along with IMPAX 6, but with the increasing emphasis on 3D and other advanced visualization techniques, they may feel the need. The value-added reseller agreement with TeraRecon gives IMPAX purchasers a wide range of advanced visualization and decision-support tools for radiology, cardiology, and nuclear medicine applications.
Advanced 3D capabilities and automated tools for volume reconstruction and image analysis are a mouse click away as part of a scalable and flexible software license that can be deployed across multiple servers. This license extends to the zero-footprint AquariusWEB viewer, which provides remote access to images, as well as vascular analyses and other quantitative results.
And there is an added bonus in that AquariusWEB can connect the user to electronic medical records. The zero-footprint viewer provides an easy way to plug into EMR systems, since it can be launched from a URL referring to the iNtuition server and the patient or study.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
